Metagenomi, Inc.
MGX
$1.67
$0.159.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -24.64% | -74.81% | 57.30% | -30.34% | 2.65% |
| Total Depreciation and Amortization | 7.11% | 4.20% | 2.83% | 6.00% | 4.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 234.35% | -14.04% | -21.64% | 163.25% | -0.21% |
| Change in Net Operating Assets | -23.12% | 39.49% | -90.15% | -149.45% | 37.00% |
| Cash from Operations | 1.36% | -1.25% | 11.86% | -44.96% | 13.22% |
| Capital Expenditure | 72.17% | -80.45% | 27.32% | 47.32% | 23.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 473.40% | 37.48% | 86.81% | -250.42% | -20.19% |
| Cash from Investing | 419.51% | 31.47% | 86.24% | -256.24% | -20.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 75.79% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 30.16% |
| Cash from Financing | 100.00% | 75.79% | -102.35% | 6,587.03% | 30.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 106.29% | 12.84% | -8.76% | -198.29% | -22.97% |